Business

EVE Raises $0.9m to Advance Drug Reformulation Strategy

EVE Raises $0.9m to Advance Drug Reformulation Strategy

Eve Health Group LimitedMarch 12, 20264

EVE Raises $0.9m to Advance Drug Reformulation Strategy

About this update from Eve Health Group Limited

Eve Health Group Limited has released a press release. View Attachment

View stock analysis, news, and events for Eve Health Group Limited

More from Eve Health Group Limited

Quarterly Activities/Appendix 4C Cash Flow Report - Amended

August 6, 2026

Eve Initiates Pilot Clinical Study for Libbo ED Film

June 15, 2026

All Eve Health Group Limited news →